New Jersey START #26DPP01283

New Jersey Solicits FDA-Approved Naloxone 4mg Nasal Spray for Department of Human Services

This opportunity from the State of New Jersey seeks FDA-approved Naloxone 4mg Nasal Spray for the Department of Human Services. - Government Buyer: - Division of Purchase and Property, State of New Jersey - Department of Human Services - Delivery location: 33 West State Street, Trenton, NJ - OEMs and Vendors: - No specific OEMs or vendors named; requirement is for FDA-approved manufacturers - Products Requested: - Naloxone, 4mg Nasal Spray - Must be FDA-approved - Classified under miscellaneous drugs and pharmaceuticals (NIGP code 26972) - Quantity: Not specified (likely bulk/multi-year supply) - Unique/Notable Requirements: - Only FDA-approved Naloxone nasal spray products are eligible - Bidders must use the State-Supplied Price Sheet - No bid bond or performance bond required - Multi-year contract period - OEMs to highlight: - Focus on manufacturers of FDA-approved Naloxone nasal spray - Estimated contract value: Not specified, but likely significant due to statewide supply - Potential competitors include major pharmaceutical companies producing Naloxone nasal spray

Description

This solicitation is for the procurement of Naloxone, 4mg Nasal Spray, which is FDA-approved, intended for use by the New Jersey Department of Human Services. The procurement involves miscellaneous drugs and pharmaceuticals not otherwise classified. Bidders must submit pricing using the State-Supplied Price Sheet. The contract period is from February 8, 2027, to February 7, 2030, and the solicitation is managed by the Division of Purchase and Property in New Jersey.

View original listing